title: [Infertility treatments after gynecologic cancers and indications of ovarian tissue cryopreservation].
abstract: Increasing numbers of young people are surviving cancer, but treatment can affect their reproductive function. Female fertility is more difficult to preserve than male fertility. Fertility-sparing treatments may be possible for some women. For others, embryo cryopreservation is the only established option, provided cancer therapy can be postponed. However, cryopreservation of eggs or ovarian tissue is now becoming a real possibility. Medically assisted reproductive options for cancers survivors include ovarian stimulation, IVF and oocyte donation. Gestational surrogacy and adoption are other possibilities.
authors.affiliation: Gynécologie Obstétrique et Médecine de la Reproduction, Centre Hospitalier des 4 Villes, 141 grande Rue, 92318 Sèvres cedex. j.belaischallart@ch4v.fr
authors.forename: Joëlle
authors.initials: J
authors.lastname: Belaisch-Allart
authors.forename: Sophie
authors.initials: S
authors.lastname: Bringer-Deutch
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015925:Cryopreservation; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications / Q000628:therapy*; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy*; D010053:Ovary; D011878:Radiotherapy / Q000009:adverse effects; D027724:Reproductive Techniques, Assisted
chemical_list: D000970:Antineoplastic Agents